For the quarter ended January 2024, Veeva Systems (VEEV) reported revenue of $630.62 million, up 11.9% over the same period last year. EPS came in at $1.38, compared to $1.15 in the year-ago quarter. The reported revenue represents a surprise of +1.59% over the Zacks Consensus Estimate of $620.75 million. With the consensus EPS estimate being $1.30, the EPS surprise was +6.15%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall St ...

Veeva Systems (VEEV) came out with quarterly earnings of $1.38 per share, beating the Zacks Consensus Estimate of $1.30 per share. This compares to earnings of $1.15 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 6.15%. A quarter ago, it was expected that this provider of cloud-based software services for the life sciences industry would post earnings of $1.28 per share when it actually produced earnings of $1.34, delivering ...

Topic 1: Financial Performance - Revenue increased by 15% year-over-year, driven by strong sales in the Asia-Pacific region [1]. - Net profit margin improved to 12%, up from 10% in the previous quarter [2]. - Operating expenses rose by 8%, primarily due to increased marketing and R&D investments [3]. Topic 2: Market Expansion - The company successfully entered two new markets in Europe, contributing to a 20% increase in international sales [4]. - A new distribution center was opened in South America to support regional growth [1]. - Strategic partnerships were formed with local retailers in Southeast Asia to enhance market penetration [3]. Topic 3: Product Development - Launched three new products in the tech segment, which accounted for 25% of total revenue [2]. - R&D spending increased by 10% to accelerate innovation and product differentiation [4]. - Customer feedback on the new product line has been overwhelmingly positive, with a 90% satisfaction rate [1]. Topic 4: Operational Efficiency - Implemented new supply chain management software, reducing logistics costs by 5% [3]. - Streamlined manufacturing processes, resulting in a 7% increase in production output [2]. - Employee training programs were expanded, leading to a 15% improvement in operational efficiency [4]. Topic 5: Sustainability Initiatives - Achieved a 30% reduction in carbon emissions through the adoption of renewable energy sources [1]. - Introduced eco-friendly packaging for all product lines, reducing plastic usage by 20% [3]. - Committed to achieving net-zero emissions by 2030, with a detailed roadmap published in the latest sustainability report [2]. Topic 6: Corporate Governance - Appointed two new independent directors to the board, enhancing governance and oversight [4]. - Conducted a comprehensive review of corporate policies to ensure compliance with global standards [1]. - Increased transparency by publishing detailed quarterly reports and holding regular investor briefings [3].

Mid-sized pharmaceutical company sets digital foundation to drive more effective and precise engagement BARCELONA, Spain, Feb. 27, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that mid-sized pharmaceutical company Dr.Pfleger Arzneimittel GmbH has selected Veeva Commercial Cloud, including Veeva CRM and Veeva CLM, alongside Veeva OpenData. With Veeva Commercial Cloud, Dr.Pfleger's field team can lead more effective field engagement in Germany and Austria, reaching the right healthcare prof ...

Wall Street analysts expect Veeva Systems (VEEV) to post quarterly earnings of $1.30 per share in its upcoming report, which indicates a year-over-year increase of 13%. Revenues are expected to be $620.75 million, up 10.2% from the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 0.2% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Before a company announces it ...

Veeva Systems Inc. (VEEV) is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid third-quarter fiscal 2024 performance and strategic deals, is expected to contribute further. Stiff competition and data security threats persist.Over the past six months, this currently Zacks Rank #2 (Buy) stock has risen 16.6% compared with 40.9% growth of the industry and a 13.2% rise of the S&P 500 Composite.The renowned provider of cloud-based software appli ...

Veeva System (VEEV) recently announced that Boehringer Ingelheim, a global animal health leader, has selected Veeva Vault Clinical and Veeva Vault RIM applications as its technology foundation for clinical and regulatory management of its health business unit.Boehringer can expedite clinical execution for the development of new medications that improve animals' quality of life by implementing unified apps on a single platform.Price PerformanceFor the past six months, VEEV’s shares have gained 15.4% compared ...

Global animal health leader adopts Veeva Vault Clinical and Veeva Vault RIM for greater efficiency, visibility, and speed PLEASANTON, Calif., Feb. 14, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Boehringer Ingelheim has selected Veeva Vault Clinical and Veeva Vault RIM applications as its technology foundation for clinical and regulatory management in its animal health business unit. By adopting unified applications on a single platform, Boehringer Ingelheim can streamline clinical ...

Online training program guides users from regulatory planning to submissionPLEASANTON, Calif., Feb. 12, 2024 /PRNewswire/ -- DIA RSIDM 2024 — Veeva Systems (NYSE: VEEV) today announced Veeva Vault Submissions Publishing eLearning, a new regulatory information management (RIM) application that educates users on key publishing processes for seamless development of compliant content. With on-demand process-based training, companies can quickly onboard employees to use Veeva Vault Submissions Publishing while i ...

Veeva Systems (VEEV) ended the recent trading session at $204.24, demonstrating a -1.24% swing from the preceding day's closing price. The stock fell short of the S&P 500, which registered a loss of 0.32% for the day. Elsewhere, the Dow saw a downswing of 0.71%, while the tech-heavy Nasdaq depreciated by 0.2%.Prior to today's trading, shares of the provider of cloud-based software services for the life sciences industry had gained 11.37% over the past month. This has outpaced the Computer and Technology sec ...